Research Phase. The Parties have agreed upon an initial Research Plan for each of the Fibrosis Application R&D Program, the Muscle Application R&D Program, and the Acetylome Application R&D Program, attached hereto as Exhibit A-▇, ▇-▇ ▇▇▇ ▇-▇, respectively. The applicable Research Plan shall govern the Parties’ respective activities under each R&D Program during the Research Term. Each Research Plan shall include a set of mutually-agreed feasibility studies (“Stage 1 activities”) and a set of novel Biomarker discovery activities (“Stage 2 activities”). The Stage 1 activities and Stage 2 activities under each Research Plan shall collectively make up the research phase (“Research Phase”) of each R&D Program. Each Research Plan will include a detailed plan for the conduct of activities in the first year of the Research Term for the applicable R&D Program. Such first year of activities is anticipated to include Stage 1 activities and, if initiated by GSK during this time, Stage 2 activities, in each case as more fully set forth in the applicable Research Plans. Each Research Plan will include the timelines for such activities associated with the Stage 1 and anticipated activities for Stage 2 activities. Each Research Plan will also include a more general outline of the plan for the conduct of activities in the second and third years of the Research Term for each applicable R&D Program. In the event that the Parties mutually agree to extend the Research Term of an R&D Program, the Parties, via the JRS, will discuss and agree upon a detailed Research Plan for activities to be conducted by each Party during the extended Research Term for such R&D Program.
Appears in 2 contracts
Sources: Collaboration and License Agreement (Kinemed Inc), Collaboration and License Agreement (Kinemed Inc)